TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/28/21 21:32 | 5/27/21 | ORGO | Organogenesis Holdings Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ades Alan A. | NJ | DT | S | -63,755 | 16.40 | 0 | -3,888 | -6 | 59,837 | D | |||||||||||||||
2/16/21 20:12 | 2/11/21 | ORGO | Organogenesis Holdings Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ades Alan A. | NJ | DT | S | -650 | 3.25 | 0 | -200 | 0 | 68,595 | D | |||||||||||||||
11/19/20 16:53 | 11/17/20 | ORGO | Organogenesis Holdings Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ades Alan A. | NJ | DT | P | 2,708 | 3.25 | 0 | 833 | 1 | 137,243 | M | |||||||||||||||
9/10/19 18:30 | 9/6/19 | ORGO | Organogenesis Holdings Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ades Alan A. | NJ | DT | P | 50 | 5.03 | 0 | 10 | 0 | 67,962 | D | |||||||||||||||
9/5/19 20:09 | 9/3/19 | ORGO | Organogenesis Holdings Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ades Alan A. | NJ | DT | P.m | 473 | 4.50 | 0 | 105 | 0 | 67,952 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |